EULAV Asset Management’s Eli Lilly LLY Stock Holding History

EULAV Asset Management’s Portfolio LLY Stock Details LLY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$8.75M	Hold	9,510	–	–	0.28%	91
2025 Q4	$10.2M	Buy	9,510 +10	+0.1%	+$9.56K	0.27%	98
2025 Q3	$7.25M	Hold	9,500	–	–	0.17%	114
2025 Q2	$7.41M	Buy	+9,500	New	+$7.38M	0.17%	112
2014 Q2	–	Sell	-22,500	Closed	-$1.32M	–	398
2014 Q1	$1.32M	Hold	22,500	–	–	0.07%	298
2013 Q4	$1.15M	Buy	22,500 +3,000	+15%	+$150K	0.06%	317
2013 Q3	$981K	Sell	19,500 -500	-3%	-$26.2K	0.06%	331
2013 Q2	$982K	Buy	+20,000	New	+$1.09M	0.06%	335

Other funds holding LLY

Lilly Endowment Indiananapolis, Indiana $108B AUM 53.87% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

PNC Financial Services Group Pittsburgh, Pennsylvania $173B AUM 20.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

EULAV Asset Management's LLY Position: Q1 2026 in Review

EULAV Asset Management held its Eli Lilly (LLY) position steady in Q1 2026 at 9,510 shares worth $8.75M. The position accounts for 0.28% of the portfolio, ranked #91.

EULAV Asset Management first reported a position in LLY in Q2 2013 and has held it in 8 quarters since. The position peaked at $10.2M in Q4 2025. 4,353 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

EULAV Asset Management held 9,510 shares of Eli Lilly worth $8.75M as of Q1 2026.
EULAV Asset Management left its Eli Lilly share count unchanged in Q1 2026.
Eli Lilly made up 0.28% of EULAV Asset Management's portfolio in Q1 2026, its #91 holding.
EULAV Asset Management first reported a position in Eli Lilly in Q2 2013 and has held it in 8 quarters since.
EULAV Asset Management's Eli Lilly position peaked at $10.2M in Q4 2025.
4,353 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on EULAV Asset Management's 13F filing for Q1 2026, filed 7 May 2026.